Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents
RNA · 2024
DOI: 10.1261/rna.079904.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2024. Verfasst von Gavin M Traber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Sacramento, California 95817, USA. Hauptthemen laut MEDLINE: Bioengineering, RNA, Transfer, Gly, RNA, Transfer, Leu, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Genome-derived microRNAs (miRNA or miR) govern posttranscriptional gene regulation and play important roles in various cellular processes and disease progression. While chemo-engineered miRNA mimics or biosimilars made in vitro are widely available and used, miRNA agents produced in vivo are emerging to closely recapitulate natural miRNA species for research. Our recent works have demonstrated the success of high-yield, in vivo production of recombinant miRNAs by using human tRNA (htRNA) fused precursor miRNA (pre-miR) carriers. In this study, we aim to compare the production of bioengineered RNA (BioRNA) molecules with glycyl versus leucyl htRNA fused hsa-pre-miR-34a carriers, namely BioRNA Gly and BioRNA Leu , respectively, and perform initial functional assessment. We designed, cloned, overexpressed, and purified a total of 48 new BioRNA/miRNAs, and overall expression levels, final yields, and purities were revealed to be comparable between BioRNA Gly and BioRNA Leu molecules. Meanwhile, the two versions of BioRNA/miRNAs showed similar activities to inhibit non-small cell lung cancer cell viability. Interestingly, functional analyses using model BioRNA/miR-7-5p demonstrated that BioRNA Gly /miR-7-5p exhibited greater efficiency to regulate a known target gene expression (EGFR) than BioRNA Leu /miR-7-5p, consistent with miR-7-5p levels released in cells. Moreover, BioRNA Gly /miR-7-5p showed comparable or slightly greater activities to modulate MRP1 and VDAC1 expression, compared with miRCURY LNA miR-7-5p mimic. Computational modeling illustrated overall comparable 3D structures for exemplary BioRNA/miRNAs with noticeable differences in htRNA species and payload miRNAs. These findings support the utility of hybrid htRNA/hsa-pre-miR-34a as reliable carriers for RNA molecular bioengineering, and the resultant BioRNAs serve as functional biologic RNAs for research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Sacramento, California 95817, USA.
- Department of Biochemistry and Molecular Medicine, University of California-Davis, School of Medicine, Sacramento, California 95817, USA aimyu@ucdavis.edu.
ORCID-Profile: Gavin M Traber, Ai-Ming Yu
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Traber, G. M., Yi, C., Batra, N., Tu, M. J., & Yu, A. M. (2024). Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA. https://doi.org/10.1261/rna.079904.123
Vancouver
Traber GM, Yi C, Batra N, Tu MJ, Yu AM. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents. RNA. 2024. doi:10.1261/rna.079904.123
BibTeX
@article{Traber2024,
author = {Traber, Gavin M and Yi, Colleen and Batra, Neelu and Tu, Mei-Juan and Yu, Ai-Ming},
title = {Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents},
journal = {RNA},
year = {2024},
doi = {10.1261/rna.079904.123}
}
EUVIMED